74 studies found for:    graves
Show Display Options
Rank Status Study
21 Active, not recruiting Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)
Condition: Graves´ Disease
Interventions: Drug: Diclofenac;   Drug: Methimazole;   Drug: L-thyroxin;   Drug: Propranolol;   Drug: Metoprolol
22 Recruiting Radioactive Iodide Therapy for Pediatric Graves' Disease
Condition: Graves' Disease
Interventions: Radiation: RAI treatment;   Drug: ATD Group
23 Active, not recruiting Remission Induction and Sustenance in Graves' Disease 2
Conditions: Graves Disease;   Hyperthyroidism
Intervention: Other: Stop medication
24 Completed TSH Receptor Antibody Heterogeneity in Children and Adolescents With Graves' Disease
Condition: Graves' Disease
Intervention:
25 Completed Genetic Polymorphisms Associated With Cigarette Smoking and Risk of Graves’ Disease
Condition: Graves' Disease
Intervention:
26 Unknown  Phase II Randomized Controlled Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy
Condition: Graves' Disease
Intervention: Procedure: Radiotherapy
27 Completed Evaluation of Optimal Time of Methimazole Discontinuation Before Radio-iodine Therapy in Hyperthyroid Grave's Patients
Condition: Graves Disease
Intervention: Drug: Methimazole
28 Recruiting Early Levothyroxine Post Radioactive Iodine
Condition: Graves' Disease
Intervention: Drug: Levothyroxine
29 Terminated Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune Treatment
Condition: Graves Ophthalmopathy
Interventions: Drug: Methimazole;   Drug: Bromocriptine;   Drug: Pentoxifylline
30 Not yet recruiting Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)
Condition: Graves' Ophthalmopathy
Interventions: Drug: Bimatoprost;   Drug: Eye drop solution
31 Terminated A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease
Condition: Graves Ophthalmopathy
Interventions: Drug: Otelixizumab - low dose;   Drug: Otelixizumab - medium low dose;   Drug: Otelixizumab - medium high dose;   Drug: Otelixizumab - high dose;   Drug: Otelixizumab;   Drug: Methylprednisolone
32 Completed Thyroid Treatment Trial
Condition: Graves Ophthalmopathy
Intervention: Drug: Intravenous Methylprednisolone + Oral Methotrexate vs Intravenous Methylprednisolone + Placebo
33 Unknown  The Role of TSH Receptor, PPAR-r, IGF-1R, IGF and Cytokines in Different Stages of Graves’Ophthalmopathy
Condition: Graves' Ophthalmopathy
Intervention:
34 Unknown  Application of Digital Infrared Thermal Imaging (DITI) in Graves' Disease
Condition: Graves' Disease
Intervention:
35 Completed Morphometric Analysis of Orbital Structures in Graves´ Orbitopathy
Condition: Dysthyroid Orbitopathy
Intervention:
36 Completed Differential Diagnosis of STA-PSV in Thyrotoxicosis
Conditions: Thyrotoxicosis;   Peak Systolic Velocity of Superior Thyroid Artery;   Thyroiditis;   Graves Disease
Intervention:
37 Unknown  Use of Botox in the Management of Thyroid Related Upper Eyelid Retraction
Condition: Graves Ophthalmopathy
Interventions: Drug: Botulinum Toxin Type A;   Drug: Saline injection
38 Completed Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies
Condition: Graves' Ophthalmopathy
Intervention: Drug: Carbimazole, radio-active iodine (I131)
39 Completed Antithyroid Drugs During Radioiodine Therapy
Conditions: Toxic Nodular Goitre;   Graves Disease
Intervention: Drug: Methimazole
40 Completed rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter
Conditions: Benign Nontoxic and Toxic Goiter;   Graves' Disease
Intervention: Drug: Recombinant human thyrotropin (Thyrogen)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years